Blood Pressure Control May Prevent Over 100,000 Deaths
According to findings from a new study presented at ASN Kidney Week November 15-20 November 2016 at McCormick Place in Chicago, IL, intensive blood pressure lowering may prevent more than 100,000 deaths in the U.S. each year.
The Systolic Blood Pressure Intervention Trial (SPRINT) trial, the largest study of its kind, was conducted with more than 9300 participants aged 50 and older with high blood pressure. Patients were assigned to a systolic blood pressure target of 120 mm Hg or the 140mm Hg and were prescribed medication accordingly. Findings showed that intensive systolic blood pressure lowering to 120 mm Hg prolonged life compared with the standard SBP lowering to 140mm Hg.
See Also: SPRINT Study: Lowering Blood Pressure Lowers CVD Events
Tisha Joerla Tan, MD (Loyola University Medical Center) and her colleagues applied the study's findings to similar individuals in the general US population. Approximately 18.1 million US adults met SPRINT criteria. Intensive blood pressure lowering was projected to prevent nearly 105,000 deaths per year.
"Our analyses also showed that more than 4 million adults with stage 3-4 chronic kidney disease meet SPRINT criteria, and intensive systolic blood pressure lowering was projected to prevent 32,800 deaths per year in this group," said Dr. Tan.
Source: American Society of Nephrology
Image Credit: Pixabay
Published on : Sun, 20 Nov 2016
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...
The CNAP® Monitor represents the next generation of noninvasive patient monitoring by merging the advantages of noninvasive, risk‐free methods with the benefits of continuity in the same accuracy as invasive standards. The advanced parameter set enables...